Roy Swiger, PhD, Chief Executive Officer
Dr Swiger received his Ph.D. in molecular genetics from York University in Toronto. He has conducted research and development in the areas of clinical Dx, forensics, and environmental testing for nearly 30 yrs. He has participated in developing numerous applications and devices that have been patented or licensed and widely applied in government, commercial, and testing-services business sectors. More recently has held executive roles in a handful of startups and was formerly the Senior VP of Research and Development at ImpeDx.
Stephen O’Connor, PhD, Co-Founder and Executive Chairman of the Board of Directors
Dr. O’Connor received his Ph.D in Physical Chemistry from the California Institute of Technology in 1995. He has been a serial entrepreneur in the technology focused sector for the past 20 years. He has co-founded and managed more than 10 companies in the past with multiple successful exits, many of which were in the diagnostic sector. He brings to ImpeDx Diagnostics significant experience in technology development, intellectual property, fundraising, business partnering, and company building.
Shramik Sengupta, PhD, Co-Founder and Chief Technology Officer
Dr. Sengupta received his Ph.D. in Bio-medical Engineering from the University of Minnesota in 2004. He is an Associate Professor of Bio-Engineering at the University of Missouri, and the lead inventor of the company’s core technology. Dr. Sengupta also acts as the part-time CTO of ImpeDx Diagnostics. He not only brings detailed technical knowledge of the core technology, but also expertise on adapting the platform for other applications (such as antibiotic resistance profiling of isolated strains, water-borne pathogen testing, etc.).